Delhi: With panic gripping all over the globe as new mutated strands of Coronavirus are being discovered, Serum Institute of India (SII) on Monday said that some "good news" is expected soon in terms of vaccination in India. Adar Poonawalla, CEO of SII and the local maker of coronavirus vaccine Oxford-AstraZeneca, said the British and Indian governments may approve shots for emergency use within a few days.

"You will hear good news from the UK soon, UK regulator may approve by end of this December or by early January, then we may get an approval in India too,” Poonawalla said during a launch event of the Pneumococcal Conjugate vaccine.

At the event he also said,  Oxford-AstraZeneca has stockpiled 40-50 million doses of the “Covishield” for India. He added once the vaccine gets the approval, it will be on the government on how fast the inoculation process can be expedited.

“We have 40-50 million doses of Covishield stockpiled. Once we get regulatory approvals in a few days, it'll be down to the Govt to decide how much they can take and how fast. We will be producing around 300 million doses by July 2021”, said SII CEO.

READ | AstraZeneca CEO Claims His Vaccine Gives 100% Protection Against Coronavirus

As India in the next six to eight months, wants to deliver 600 million vaccine shots of Covid-19, it may also consider giving approvals to Pfizer and BioNTech vaccine and another developed by India's Bharat Biotech.

As a vaccine is likely to get approved by India's top drug regulator, the country is getting ready for the mass immunization programme against the Covid-19 disease.

ALSO READ | US Doctor Reports Severe Allergic Reaction To Moderna's Covid-19 Vaccine; Here's What He Revealed

In the last 24-hours the country witnessed 20,021 new Covid-19 cases, 21,131 recoveries, and 279 deaths. India currently stands at second position with 1,02,07,871 total number of cases.